title: Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
abstract: The 13th St Gallen International Breast Cancer Conference (2013) Expert Panel reviewed and endorsed substantial new evidence on aspects of the local and regional therapies for early breast cancer, supporting less extensive surgery to the axilla and shorter durations of radiation therapy. It refined its earlier approach to the classification and management of luminal disease in the absence of amplification or overexpression of the Human Epidermal growth factor Receptor 2 (HER2) oncogene, while retaining essentially unchanged recommendations for the systemic adjuvant therapy of HER2-positive and 'triple-negative' disease. The Panel again accepted that conventional clinico-pathological factors provided a surrogate subtype classification, while noting that in those areas of the world where multi-gene molecular assays are readily available many clinicians prefer to base chemotherapy decisions for patients with luminal disease on these genomic results rather than the surrogate subtype definitions. Several multi-gene molecular assays were recognized as providing accurate and reproducible prognostic information, and in some cases prediction of response to chemotherapy. Cost and availability preclude their application in many environments at the present time. Broad treatment recommendations are presented. Such recommendations do not imply that each Panel member agrees: indeed, among more than 100 questions, only one (trastuzumab duration) commanded 100% agreement. The various recommendations in fact carried differing degrees of support, as reflected in the nuanced wording of the text below and in the votes recorded in supplementary Appendix S1, available at Annals of Oncology online. Detailed decisions on treatment will as always involve clinical consideration of disease extent, host factors, patient preferences and social and economic constraints.
authors.affiliation: International Breast Cancer Study Group, Division of Medical Oncology, European Institute of Oncology, Milan, Italy. aron.goldhirsch@ibcsg.org
authors.forename: A
authors.initials: A
authors.lastname: Goldhirsch
authors.forename: E P
authors.initials: EP
authors.lastname: Winer
authors.forename: A S
authors.initials: AS
authors.lastname: Coates
authors.forename: R D
authors.initials: RD
authors.lastname: Gelber
authors.forename: M
authors.initials: M
authors.lastname: Piccart-Gebhart
authors.forename: B
authors.initials: B
authors.lastname: Thürlimann
authors.forename: H-J
authors.initials: HJ
authors.lastname: Senn
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D008408:Mastectomy; D057285:Precision Medicine / Q000379:methods*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human
keywords: St Gallen Consensus; early breast cancer; radiation therapy; subtypes; surgery; systemic adjuvant therapies
references.citation: J Med Econ. 2013;16(1):30-40
references.pmid: 22966753
references.citation: Breast Cancer Res Treat. 2012 Feb;131(3):819-25
references.pmid: 21468637
references.citation: Breast. 2013 Aug;22 Suppl 2:S137-40
references.pmid: 24074774
references.citation: J Clin Oncol. 2012 Jun 20;30(18):2218-26
references.pmid: 22585699
references.citation: J Clin Oncol. 2010 Jul 20;28(21):3411-5
references.pmid: 20547990
references.citation: Cancer. 2012 Apr 15;118(8):1982-8
references.pmid: 21887681
references.citation: J Clin Oncol. 2011 Jul 1;29(19):2653-9
references.pmid: 21555684
references.citation: J Clin Oncol. 2012 Aug 20;30(24):2977-80
references.pmid: 22802308
references.citation: Oncologist. 2010;15(5):457-65
references.pmid: 20421264
references.citation: Cancer. 1991 Aug 1;68(3):549-57
references.pmid: 1648433
references.citation: Breast. 2013 Aug;22 Suppl 2:S149-51
references.pmid: 24074777
references.citation: J Natl Cancer Inst. 2008 Feb 6;100(3):207-12
references.pmid: 18230798
references.citation: J Natl Cancer Inst. 2011 Sep 7;103(17):1299-309
references.pmid: 21743022
references.citation: Breast. 2013 Aug;22 Suppl 2:S106-9
references.pmid: 24074769
references.citation: Biochim Biophys Acta. 2012 Aug;1826(1):209-14
references.pmid: 22546620
references.citation: Breast. 2013 Aug;22 Suppl 2:S110-4
references.pmid: 24074770
references.citation: JAMA. 2011 Feb 9;305(6):569-75
references.pmid: 21304082
references.citation: Lancet. 2012 Feb 4;379(9814):432-44
references.pmid: 22152853
references.citation: Genet Med. 2013 Mar;15(3):203-11
references.pmid: 22975761
references.citation: Cancer Discov. 2012 Nov;2(11):1048-63
references.pmid: 22915751
references.citation: Cancer Discov. 2013 Jan;3(1):27-34
references.pmid: 23319768
references.citation: J Clin Oncol. 2010 Jan 1;28(1):105-13
references.pmid: 19917869
references.citation: Breast. 2013 Aug;22 Suppl 2:S96-9
references.pmid: 24074802
references.citation: Breast. 2013 Aug;22 Suppl 2:S156-60
references.pmid: 24074779
references.citation: Breast. 2012 Oct;21(5):678-81
references.pmid: 22835916
references.citation: Breast. 2013 Aug;22 Suppl 2:S38-43
references.pmid: 24074790
references.citation: J Clin Oncol. 2013 Mar 1;31(7):860-7
references.pmid: 23341518
references.citation: Br J Cancer. 1998 Aug;78(4):460-5
references.pmid: 9716027
references.citation: J Clin Oncol. 2012 May 20;30(15):1796-804
references.pmid: 22508812
references.citation: J Clin Oncol. 2006 Aug 10;24(23):3726-34
references.pmid: 16720680
references.citation: J Natl Cancer Inst. 2011 Nov 16;103(22):1656-64
references.pmid: 21960707
references.citation: Breast. 2013 Aug;22 Suppl 2:S180-3
references.pmid: 24074784
references.citation: Nature. 2012 Oct 4;490(7418):61-70
references.pmid: 23000897
references.citation: Breast. 2013 Aug;22 Suppl 2:S165-70
references.pmid: 24074781
references.citation: Ann Oncol. 2012 Nov;23(11):2866-2873
references.pmid: 22532584
references.citation: Breast Cancer Res Treat. 2012 Apr;132(3):895-915
references.pmid: 22048814
references.citation: Steroids. 2011 Jul;76(8):736-40
references.pmid: 21447351
references.citation: Breast. 2013 Aug;22 Suppl 2:S147-8
references.pmid: 24074776
references.citation: Breast. 2013 Aug;22 Suppl 2:S88-91
references.pmid: 24074800
references.citation: N Engl J Med. 2003 Nov 6;349(19):1793-802
references.pmid: 14551341
references.citation: Breast. 2013 Aug;22 Suppl 2:S141-6
references.pmid: 24074775
references.citation: Breast. 2013 Aug;22 Suppl 2:S115-7
references.pmid: 24074771
references.citation: Breast. 2013 Aug;22 Suppl 2:S57-65
references.pmid: 24074794
references.citation: Ann Oncol. 2013 Feb;24(2):355-361
references.pmid: 23028039
references.citation: Breast Cancer Res Treat. 2012 Jul;134(2):769-81
references.pmid: 22562122
references.citation: J Natl Cancer Inst. 2009 May 20;101(10):736-50
references.pmid: 19436038
references.citation: Breast. 2013 Aug;22 Suppl 2:S30-7
references.pmid: 24074789
references.citation: Lancet. 2013 Sep 21;382(9897):1021-8
references.pmid: 23871490
references.citation: Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):987-1001
references.pmid: 19545784
references.citation: Radiother Oncol. 2010 Mar;94(3):264-73
references.pmid: 20181402
references.citation: Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18060-5
references.pmid: 23077249
references.citation: J Clin Oncol. 2005 Oct 10;23(29):7265-77
references.pmid: 16145055
references.citation: Breast. 2013 Aug;22 Suppl 2:S129-36
references.pmid: 24074773
references.citation: J Natl Cancer Inst. 2007 Jan 17;99(2):167-70
references.pmid: 17228000
references.citation: N Engl J Med. 2010 Feb 11;362(6):513-20
references.pmid: 20147717
references.citation: J Natl Cancer Inst. 2012 Jan 4;104(1):56-66
references.pmid: 22138097
references.citation: Br J Cancer. 2007 May 21;96(10):1504-13
references.pmid: 17453008
references.citation: Cancer. 2003 Mar 1;97(5):1321-31
references.pmid: 12599241
references.citation: N Engl J Med. 2009 May 14;360(20):2055-65
references.pmid: 19439741
references.citation: Breast. 2013 Aug;22 Suppl 2:S66-72
references.pmid: 24074795
references.citation: Ann Oncol. 2011 Aug;22(8):1736-47
references.pmid: 21709140
references.citation: Am J Manag Care. 2011;17(7):455-64
references.pmid: 21819166
references.citation: Breast. 2013 Aug;22 Suppl 2:S8-11
references.pmid: 24074798
references.citation: Ann Oncol. 2013 Mar;24(3):618-24
references.pmid: 23136233
references.citation: Int J Cancer. 2013 Jun 15;132(12):2918-27
references.pmid: 23180513
references.citation: Breast Cancer Res Treat. 2012 Jun;133(2):759-68
references.pmid: 22315134
references.citation: Breast Cancer Res. 2008;10(4):R65
references.pmid: 18662380
references.citation: J Clin Oncol. 2009 Mar 10;27(8):1160-7
references.pmid: 19204204
references.citation: J Clin Oncol. 2013 Jan 10;31(2):203-9
references.pmid: 23233704
references.citation: Ann Surg. 2002 Jan;235(1):10-26
references.pmid: 11753038
references.citation: Acta Oncol. 1997;36(4):369-74
references.pmid: 9247096
references.citation: Eur J Cancer. 2013 Jul;49(11):2469-75
references.pmid: 23611660
references.citation: Breast. 2013 Aug;22 Suppl 2:S3-7
references.pmid: 24074788
references.citation: Lancet. 2013 Mar 9;381(9869):805-16
references.pmid: 23219286
references.citation: Lancet Oncol. 2011 Jun;12(6):527-39
references.pmid: 21570352
references.citation: Ann Oncol. 2008 Jul;19(7):1231-1241
references.pmid: 18325918
references.citation: Lancet Oncol. 2013 Jul;14(8):741-8
references.pmid: 23764181
references.citation: Breast. 2013 Aug;22 Suppl 2:S152-5
references.pmid: 24074778
references.citation: Breast Cancer Res Treat. 2010 Feb;119(3):551-8
references.pmid: 19214742
references.citation: J Clin Oncol. 2010 Jul 20;28(21):3405-7
references.pmid: 20548001
references.citation: Breast. 2013 Aug;22 Suppl 2:S22-6
references.pmid: 24074786
references.citation: J Clin Oncol. 2012 Nov 10;30(32):3967-75
references.pmid: 23045588
references.citation: Lancet Oncol. 2013 Apr;14(4):297-305
references.pmid: 23491275
references.citation: Clin Cancer Res. 2010 Nov 1;16(21):5222-32
references.pmid: 20837693
references.citation: J Biomed Biotechnol. 2011;2011:284584
references.pmid: 21760703
references.citation: Nature. 2012 Jun 10;486(7403):353-60
references.pmid: 22722193
references.citation: Int J Cancer. 2013 Aug 15;133(4):929-36
references.pmid: 23371464
references.citation: J Clin Oncol. 2008 Dec 1;26(34):5569-75
references.pmid: 18981464
references.citation: Clin Cancer Res. 2012 Apr 15;18(8):2402-12
references.pmid: 22351696
references.citation: J Natl Cancer Inst. 2012 Jul 18;104(14):1094-101
references.pmid: 22773826
references.citation: Cancer Cell. 2012 Jun 12;21(6):793-806
references.pmid: 22698404
references.citation: Cancer Discov. 2012 Nov;2(11):1036-47
references.pmid: 22915752
references.citation: Ann Surg. 2012 Dec;256(6):920-4
references.pmid: 23154393
references.citation: Ann Oncol. 2013 Feb;24(2):398-405
references.pmid: 23047045
references.citation: BMC Cancer. 2012 Oct 02;12:447
references.pmid: 23031196
references.citation: Lancet Oncol. 2010 Jan;11(1):55-65
references.pmid: 20005174
references.citation: Breast. 2013 Aug;22 Suppl 2:S83-7
references.pmid: 24074799
references.citation: N Engl J Med. 2012 Feb 9;366(6):520-9
references.pmid: 22149876
references.citation: J Clin Oncol. 2012 Apr 20;30(12):1264-7
references.pmid: 22355050
references.citation: Value Health. 2010 Jun-Jul;13(4):381-7
references.pmid: 20412544
references.citation: Lancet Oncol. 2011 Jul;12(7):631-41
references.pmid: 21641868
references.citation: Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47
references.pmid: 22144499
references.citation: Am J Manag Care. 2005 May;11(5):313-24
references.pmid: 15898220
references.citation: Breast Cancer Res Treat. 2012 Jun;133(3):1115-23
references.pmid: 22361999
references.citation: Nat Med. 2011 Jun 26;17(7):867-74
references.pmid: 21706029
references.citation: Breast. 2013 Aug;22 Suppl 2:S161-4
references.pmid: 24074780
references.citation: Ann Oncol. 2013 Mar;24(3):640-7
references.pmid: 23035151
references.citation: Breast. 2013 Aug;22 Suppl 2:S48-9
references.pmid: 24074792
references.citation: J Clin Oncol. 2012 Apr 20;30(12):1260-3
references.pmid: 22355052
references.citation: N Engl J Med. 2011 Oct 13;365(15):1396-405
references.pmid: 21995387
references.citation: Ann Oncol. 2012 Mar;23(3):582-588
references.pmid: 21610155